Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DPY19L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CDK10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SS18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPN12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNPY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELMO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP162 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD51L3-RFFL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF449 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PQBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNRC6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NABP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RALA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UQCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on